Aug 2026· Expert systems· Vol 43· 0 citations· 144 references
TL;DR
This study provides a clear and actionable framework to bridge the gap between DL‐based segmentation research and clinical deployment, and proposes a roadmap for future research focusing on lightweight architectures, edge–cloud integration, federated learning and explainable AI (XAI).
Abstract
Accurate lung nodule segmentation is essential for early lung cancer diagnosis and treatment planning. Although deep learning (DL) has significantly advanced automated segmentation, existing review studies often lack an integrated technical–clinical perspective and provide limited guidance for real‐world deployment. In this study, we conduct a systematic literature review following PRISMA 2020 guidelines, analysing 311 publications and synthesizing 113 high‐quality studies published between 2019 and 2026. This review makes three key contributions. First, we provide a structured comparison of major DL architectures, including convolutional neural networks (CNNs), transformers, generative adversarial networks (GANs) and graph neural networks (GNNs), with respect to segmentation performance and computational efficiency. Second, we identify critical barriers to clinical adoption, such as data heterogeneity, annotation scarcity, high computational cost and limited model interpretability. Third, we analyse efficiency metrics (parameters, loss function and optimization) to categorize models suitable for point‐of‐care, resource‐constrained and mobile clinical environments. Based on these findings, we propose a roadmap for future research focusing on lightweight architectures, edge–cloud integration, federated learning and explainable AI (XAI). This study provides a clear and actionable framework to bridge the gap between DL‐based segmentation research and clinical deployment.
Although deep learning-based volumetric analysis has shown great potential in addressing the shortcomings of linear tumor assessment, several challenges still impede clinical implementation, including limited data availability, variability in annotation, sensitivity to scanners and acquisition protocols, poor interpret...
Tuğçe Tezel, Mehmet Turkan, Ebru Sayilgan· Annals of Biomedical Enginee...· 0 citations
The proposed system demonstrates potential as an assistive tool for automated lung cancer screening, warranting further validation on larger and multi-institutional datasets before clinical application.
Vishwas V. Patange, Jagadish B. Jadhav, Sanjay L. Nalbalwar et al.· Scientific Reports· 0 citations
This survey extends beyond traditional and deep learning-based augmentation techniques or deep semi-supervised approaches, by explicitly focusing on medical/clinical imaging modalities, by explicitly focusing on CT, MRI, and X-ray, offering a broader perspective.
Pratiksha Gawas, S. Kamath S.· Multimedia tools and applica...· 0 citations
One of the leading causes of cancer-related mortality worldwide is lung cancer. Improving patient survival requires early and precise diagnosis. Recent developments in deep learning make it possible to analyse histopathological lung pictures automatically. Because most deep learning models are opaque and considered bla...
Prathamesh Patil, Pradnya.S.Kulkarni· 2026 4th International Confe...· 0 citations
An enhanced lung cancer classification framework that leverages intensity-driven region-of-interest (RoI) selection from publicly available benchmark datasets, including the Lung Image Database Consortium Image Collection (LIDC-IDRI) and The Cancer Imaging Archive (TCIA).
Syed Thouheed Ahmed, T. Y. Satheesha, L. H. Nagaraja et al.· BMC Medical Informatics and...· 0 citations
A comprehensive survey of UQ techniques in medical image segmentation is presented, categorizing existing approaches into Bayesian methods, deep ensembles, deterministic methods, test-time data augmentation, and hybrid models, while treating foundation-model-based UQ as a separate cross-cutting category.
Seyed Sina Ziaee, K. Ovens· Journal of Imaging· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.